0002041826-26-000003.txt : 20260901 0002041826-26-000003.hdr.sgml : 20260901 20260901170218 ACCESSION NUMBER: 0002041826-26-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260901 DATE AS OF CHANGE: 20260901 EFFECTIVENESS DATE: 20260901 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Voxcell BioInnovation Inc. CENTRAL INDEX KEY: 0002041826 ORGANIZATION NAME: EIN: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-596109 FILM NUMBER: 261351681 BUSINESS ADDRESS: STREET 1: 300-637 BAY STREET CITY: VICTORIA STATE: A1 ZIP: V8T 5L2 BUSINESS PHONE: 672-974-8850 MAIL ADDRESS: STREET 1: 300-637 BAY STREET CITY: VICTORIA STATE: A1 ZIP: V8T 5L2 D 1 primary_doc.xml X0708 D LIVE 0002041826 Voxcell BioInnovation Inc. 300-637 BAY STREET VICTORIA A1 BRITISH COLUMBIA, CANADA V8T 5L2 672-974-8850 BRITISH COLUMBIA, CANADA None None Corporation true Karolina Papera Valente 300-637 Bay Street Victoria A1 BRITISH COLUMBIA, CANADA V8T 5L2 Executive Officer Director Thomas Neumann 2145 N 90th Street Seattle WA WASHINGTON 98103 Director Marie-Helene Raigneau 118 Rue Des Chenes Chateauguay A8 QUEBEC, CANADA J6J 6E6 Director Jessica Miller 2a Percy St Toronto A6 ONTARIO, CANADA M5A 3M8 Director Mark Miller 35 Colonial Crescent Oakville A6 ONTARIO, CANADA L6J 4K8 Director Biotechnology Decline to Disclose 06b false 2026-08-19 false true Simple Agreements for Future Equity (SAFEs) and the Equity or Security to be acquired upon conversion of the SAFEs false 0 2200676 2200676 0 Amount of offering is CAD$3,058,213.50, and amount already sold is CAD$3,058,213.50. Amounts shown are based upon conversion to US Dollars at the time of this filing. false 31 0 0 72000 true false Voxcell BioInnovation Inc. /s/ Karolina Valente Karolina Valente CEO 2026-09-01